biosynthetic psilocybin Archives • ShroomStocks.ca

Skip to the content Skip to the main menu

Investing is a trip

Featured Content
Mushrooms
Psychedelics
Psilocybin
Microdosing
Media

Top Posts & Pages

Absolem Health signs a mushroom extraction deal
We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
Mydecine Innovations (MYCO.NE) files patent for MDMA-like compounds
Red Light Holland (TRIP.C) turns to virtual reality to inform customers about psychedelics
Red Light Holland (TRIP.C) throws a logo redesign party with Russell Peters and Khloe Terae

Recent Posts

Revive Therapeutics (RVV.CN) updates on psilocybin study for methamphetamine use
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Peyote at the ready: Lophos Holdings (MESC.C) expands license, lays out product specs
Peyote at the ready: Lophos Holdings (MESC.C) expands license, lays out product specs
Optimi Health (OPTI.C) transforming psychedelic treatment and wellness
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all the drugs
Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all the drugs
Reveive Therapeutics (RVV.C) finds multiple research options moving forward
Cannabis memory lane: Who’s sticking it out, who’s dead and dying
Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser

About

Investing is a trip

Home
Posts

Top Posts & Pages

Absolem Health signs a mushroom extraction deal
We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
Mydecine Innovations (MYCO.NE) files patent for MDMA-like compounds
Red Light Holland (TRIP.C) turns to virtual reality to inform customers about psychedelics
Red Light Holland (TRIP.C) throws a logo redesign party with Russell Peters and Khloe Terae

Recent Posts

Revive Therapeutics (RVV.CN) updates on psilocybin study for methamphetamine use
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Peyote at the ready: Lophos Holdings (MESC.C) expands license, lays out product specs
Peyote at the ready: Lophos Holdings (MESC.C) expands license, lays out product specs
Optimi Health (OPTI.C) transforming psychedelic treatment and wellness
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all the drugs
Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all the drugs
Reveive Therapeutics (RVV.C) finds multiple research options moving forward
Cannabis memory lane: Who’s sticking it out, who’s dead and dying
Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser

About

Search for:

Category

biosynthetic psilocybin

Category

biosynthetic psilocybin

Mydecine (MYCO.NE) signs five-year research agreement with John Hopkins University

Post date
August 18, 2021
Posted by
Piers Eaton
Posted in biosynthetic psilocybin, Biotech, Dr., Eaton, Health Science, John Hopkins, John Hopkins University, Johnson, Matthew Johnson, Mushrooms, MYCO, Nicotine Dependence, Psychedelics, Quit Smoking, Smoking
Comments
0

Theme by Anders Norén